TRACT Therapeutics, Inc.

TRACT Therapeutics, Inc.

The TRACT technology will transform the practice patterns of transplant surgeons. The patient uses their own body to balance their immune system.

Stage Product In Development
Industry Biotechnology
Location Chicago, IL, US
Currency USD
Founded 2013
Employees 1
Website http://tracttherapeutics.com (in process)

Company Summary

TRACT Therapeutics, Inc. was founded in order to commercialize the use of T regulatory (Tregs) cells for balance of a patient's own immune system. The technology will eliminate the need for lifelong toxic immunosuppressive drug therapy. We have successfully completed a successful Phase I trial in kidney recipients at Northwestern. The technology will also be developed for autoimmune disease. Phase II is ready to start Q2 2016.

Team

Gretchen Johnson

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free